Reanalysis of the immunological characteristics of scalp psoriasis: a cross-sectional study using Olink proteomics
-
By
-
Liping Zhu
-
Wei Chen
-
Ningning Shen
-
Qiang Dong
-
July 1, 2026
-
Clinical Scorecard: Reevaluation of the Immune Profile in Scalp Psoriasis: A Cross-Sectional Analysis Utilizing Olink Proteomics
At a Glance
| Category | Detail |
|---|
| Condition | Scalp Psoriasis |
| Key Mechanisms | Th1/Th17/IL-12/IL-23-dominant molecular signature with down-regulation of Th2-type cytokines. |
| Target Population | Adult patients with scalp psoriasis. |
| Care Setting | Dermatology clinical research. |
Key Highlights
- 28 differentially expressed proteins identified in lesional scalp skin of psoriasis patients.
- Significant down-regulation of IL-4 and IL-5 in scalp psoriasis patients.
- Negative correlation between Th2 cytokines and scalp-specific Investigator’s Global Assessment scores.
Guideline-Based Recommendations
Diagnosis
- Scalp psoriasis diagnosed through clinical evaluation and dermoscope examination.
Management
- Consider systemic treatments for difficult-to-treat cases.
Monitoring & Follow-up
- Assess disease severity using the scalp-specific Investigator’s Global Assessment (ss-IGA).
Risks
- Efficacy of treatments varies; risk of severe adverse events remains a concern.
Patient & Prescribing Data
Untreated adult patients with scalp psoriasis.
Patients had not received systemic immunosuppressants, biological agents, or phototherapy within the preceding 3 months.
Clinical Best Practices
- Utilize Olink proteomics for analyzing inflammatory biomarkers in scalp psoriasis.
- Consider the unique immune landscape of the scalp in treatment planning.
Related Resources & Content
